JP2023531750A5 - - Google Patents
Info
- Publication number
- JP2023531750A5 JP2023531750A5 JP2022580356A JP2022580356A JP2023531750A5 JP 2023531750 A5 JP2023531750 A5 JP 2023531750A5 JP 2022580356 A JP2022580356 A JP 2022580356A JP 2022580356 A JP2022580356 A JP 2022580356A JP 2023531750 A5 JP2023531750 A5 JP 2023531750A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- composition according
- active ingredient
- piperidinyl
- propoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026001474A JP7849574B2 (ja) | 2020-06-24 | 2026-01-07 | ゴーシェ病を処置するためのアリモクロモル |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20182067.7 | 2020-06-24 | ||
| EP20182067 | 2020-06-24 | ||
| PCT/EP2021/067366 WO2021260120A1 (en) | 2020-06-24 | 2021-06-24 | Arimoclomol for treating gaucher disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026001474A Division JP7849574B2 (ja) | 2020-06-24 | 2026-01-07 | ゴーシェ病を処置するためのアリモクロモル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531750A JP2023531750A (ja) | 2023-07-25 |
| JP2023531750A5 true JP2023531750A5 (enExample) | 2024-07-02 |
Family
ID=71143584
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022580356A Withdrawn JP2023531750A (ja) | 2020-06-24 | 2021-06-24 | ゴーシェ病を処置するためのアリモクロモル |
| JP2026001474A Active JP7849574B2 (ja) | 2020-06-24 | 2026-01-07 | ゴーシェ病を処置するためのアリモクロモル |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026001474A Active JP7849574B2 (ja) | 2020-06-24 | 2026-01-07 | ゴーシェ病を処置するためのアリモクロモル |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230226036A1 (enExample) |
| EP (1) | EP4171559B1 (enExample) |
| JP (2) | JP2023531750A (enExample) |
| KR (1) | KR20230035586A (enExample) |
| CN (1) | CN116075305A (enExample) |
| AU (1) | AU2021295437A1 (enExample) |
| BR (1) | BR112022026396A2 (enExample) |
| CA (1) | CA3183559A1 (enExample) |
| DK (1) | DK4171559T3 (enExample) |
| ES (1) | ES3056005T3 (enExample) |
| IL (1) | IL299250A (enExample) |
| MX (1) | MX2023000033A (enExample) |
| PT (1) | PT4171559T (enExample) |
| WO (1) | WO2021260120A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2013125923A (ru) * | 2010-11-30 | 2015-01-10 | Орфазиме Апс | СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU222994B1 (hu) | 1995-11-02 | 2004-01-28 | BIOREX Kutató és Fejlesztő Rt. | Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására |
| HUP9900475D0 (en) | 1999-02-26 | 1999-04-28 | Biorex Kutato Fejlesztoe Kft | O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component |
| HUP0001583A2 (hu) | 2000-04-18 | 2002-11-28 | BIOREX Kutató és Fejlesztő Rt. | Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké |
| EP2484371B1 (en) * | 2008-06-26 | 2014-12-17 | Orphazyme APS | Use of Hsp70 as a regulator of enzymatic activity |
| NZ623910A (en) * | 2009-07-28 | 2016-06-24 | Shire Human Genetic Therapies | Compositions and methods for treating gaucher disease |
| US10709700B2 (en) * | 2014-09-15 | 2020-07-14 | Orphazyme A/S | Arimoclomol formulation |
| SI3448382T1 (sl) * | 2016-04-29 | 2021-03-31 | Orphazyme A/S, c/o COBIS A/S | Arimoclomol za zdravljenje motenj, povezanih z glukocerebrozidazo |
| KR102279347B1 (ko) * | 2016-12-15 | 2021-07-21 | 한국생명공학연구원 | 피리딘계 화합물을 유효성분으로 함유하는 dyrk 관련 질환의 예방 또는 치료용 약학적 조성물 |
-
2021
- 2021-06-24 WO PCT/EP2021/067366 patent/WO2021260120A1/en not_active Ceased
- 2021-06-24 PT PT217331602T patent/PT4171559T/pt unknown
- 2021-06-24 DK DK21733160.2T patent/DK4171559T3/da active
- 2021-06-24 KR KR1020237002548A patent/KR20230035586A/ko active Pending
- 2021-06-24 MX MX2023000033A patent/MX2023000033A/es unknown
- 2021-06-24 ES ES21733160T patent/ES3056005T3/es active Active
- 2021-06-24 BR BR112022026396A patent/BR112022026396A2/pt unknown
- 2021-06-24 US US18/011,349 patent/US20230226036A1/en active Pending
- 2021-06-24 CA CA3183559A patent/CA3183559A1/en active Pending
- 2021-06-24 CN CN202180056347.6A patent/CN116075305A/zh active Pending
- 2021-06-24 EP EP21733160.2A patent/EP4171559B1/en active Active
- 2021-06-24 IL IL299250A patent/IL299250A/en unknown
- 2021-06-24 JP JP2022580356A patent/JP2023531750A/ja not_active Withdrawn
- 2021-06-24 AU AU2021295437A patent/AU2021295437A1/en active Pending
-
2026
- 2026-01-07 JP JP2026001474A patent/JP7849574B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4925074B2 (ja) | ミルタザピンと１種以上の選択的セロトニン再取り込み阻害剤とを含む医薬組成物 | |
| TWI776407B (zh) | 激動劑形成之調配物及使用其之方法 | |
| KR101125462B1 (ko) | 모다피닐의 제약 제제 | |
| US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| CN111050764A (zh) | β-羟基丁酸酯和丁二醇的S对映异构体及其使用方法 | |
| JPS6143112A (ja) | 精神性欲機能障害治療剤 | |
| EA004312B1 (ru) | Применение эйкозапентаеновой и/или докозагексаеновой жирных кислот и/или их этиловых эфиров для приготовления лекарственного средства для снижения уровня смертности пациентов, перенесших инфаркт миокарда | |
| AU2019201575A1 (en) | Compositions and methods for treatment of chronic fatigue | |
| JP2022554276A5 (enExample) | ||
| JPS59112948A (ja) | コレステロ−ルレベル低下剤 | |
| US4880833A (en) | Synergistic pharmaceutical compositions, their production and use | |
| JP2015535241A (ja) | 脳機能低下の予防または改善剤 | |
| EP1383495A1 (en) | Duloxetine for treatment of hot flashes | |
| WO2008091704A2 (en) | Treatment of cushing's syndrome and autism | |
| US20020091103A1 (en) | Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder | |
| US6180680B1 (en) | Pharmaceutical compositions comprising alkanoyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism | |
| WO2004006908A1 (ja) | 色素沈着改善治療薬 | |
| ZA200106199B (en) | Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity. | |
| Capildeo et al. | Single‐dose pizotifen, 1.5 mg nocte: a new approach in the prophylaxis of migraine | |
| US4954505A (en) | Use of oxoquinazoline derivatives in the treatment of hyperuricaemia | |
| US20040152733A1 (en) | Duloxetine for treatment of hot flashes | |
| EP3804705B1 (en) | Pharmaceutical composition for preventing diabetes and use thereof | |
| US3932652A (en) | Antidepressant compositions | |
| KR20190021180A (ko) | 퇴행성 신경질환 치료용 복합 제형 조성물 | |
| US20230028539A1 (en) | Pharmaceutical composition, complementary kit and application thereof |